The Alcohol Withdrawal Syndrome: Neurobiology of Treatment and Toxicity

References

• Breier A, Paul S. The GABAA-benzodiazepine receptor: implications for the molecular basis of anxiety. J Psychiatr Res 1990; 24: 91–104
   Google Scholar
• Sudzak P E, Schwartz R D, Skolnick P, et al. Ethanol stimulates GABA-receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci U S A 1986; 83: 4071–4075
   Google Scholar
• Morrow A L, Suzdak P D, Karanian J W, et al. Chronic ethanol administration alters 7-aminobutyric acid, pentobarbital and ethanol-mediated 36Cl− uptake in cerebral cortical synaptoneurosomes. J Pharmacol Exp Ther 1988; 246: 158–164
   PubMed Web of Science ®Google Scholar
• Nutt DJ. Pharmacologic mechanisms of benzodiazepine withdrawal. J Psychiatr Res 1990; 24: 105–110
   Google Scholar
• Buck K J, Harris RA. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. J Pharmacol Exp Ther 1990; 253: 713–719
   Google Scholar
• Becker H C, Anton RF. The benzodiazepine inverse agonist Ro 15-4513 exacerbates, but does not precipitate, ethanol withdrawal in mice. Pharmacol Biochem Behav 1989; 32: 162–167
   Google Scholar
• Barbaccia M H, Costa E, Ferrero P, et al. Diazepam-binding inhibitor: a brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease. Arch Gen Psychiatry 1986; 43: 1143–1147
   Google Scholar
• Adinoff B, Majchrowicz E, Martin P R, et al. The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome. Biol Psychiatry 1986; 21: 643–649
   Google Scholar
• Little H R, Taylor S C, Nutt D J, et al. The benzodiazepine antagonist, Ro 15-1788, does not decrease ethanol withdrawal convulsions in rats. Eur J Pharmacol 1985; 107: 375–377
   Google Scholar
• File S E, Baldwin H A, Hitchcott PK. Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharm 1989; 98: 262–264
   Google Scholar
• Buck K J, Heim H, Hairis RA. Reversal of alcohol dependence and tolerance by a single administration of flumazenil. J Pharmacol Exp Ther 1991; 257: 984–989
   PubMedGoogle Scholar
• Lovinger D B, White G, Weight R. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989; 243: 1721–1724
   PubMed Web of Science ®Google Scholar
• Grant E, Valverius P, Hudspith M, et al. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 1990; 176: 289–296
   PubMed Web of Science ®Google Scholar
• Morgan P R, Nadi N S, Karanian J, et al. Mapping rat brain structures activated during ethanol withdrawal: role of glutamate and NMDA receptors. Eur J Pharmacol 1992; 225: 217–223
   Google Scholar
• Danysz W, Dyr W, Jankowska E, et al. The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol Clin Exp Res 1992; 16: 499–504
   Google Scholar
• Grant K A, Snell L D, Rogawski M A, et al. Comparison of the effects of the uncompetitive N-methyl-D aspart-ate antagonist (±)-5-arninocarbonyl-10,11-dihydro-5H-dibenzota, dk7clohepten-5,10-unine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Ther 1992; 260: 1017–1022
   Google Scholar
• Morrisett R A, Resvani A H, Overstreet D, et al. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur J Pharmacol 1990; 176: 103–105
   Google Scholar
• Olney J W, Labruyere J, Price M T, et al. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360–1362
   PubMed Web of Science ®Google Scholar
• Hawley R J, Major L F, Schulman E A, et al. Cerebrospinal fluid 3-methoxy-4 hydroxyphenglycol and norepinephrine levels in alcohol withdrawal. Arch Gen Psychiatry 1985; 42: 1056–1062
   PubMed Web of Science ®Google Scholar
• Sjoquist B, Borg S, Kvande H. Catecholamine-de-rived compounds in urine and cerebrospinal fluid from alcoholics during and after longstanding intoxication. Substance and Alcohol Actions-Misuse 1981; 2: 63–72
   Google Scholar
• Zilm D H, Sellars E H, MacLeod S M, et al. Propanolol effect on tremor in alcohol withdrawal. Ann Intern Med 1975; 83: 234–236
   PubMed Web of Science ®Google Scholar
• Kraus M L, Gottlieb L D, Horwitz F I, et al. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313: 905–909
   PubMed Web of Science ®Google Scholar
• Baumgartner G R, Rowen RC. Clonidine vs. chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 147: 1223–1226
   PubMed Web of Science ®Google Scholar
• Bjorkzvist SE. Clonidine in alcohol withdrawal. Aaa PsychiatrScand 1975; 52: 256–263
   Google Scholar
• Wilkins A J, Jenkins W J, Steiher JA. Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology 1983; 81: 78–80
   PubMed Web of Science ®Google Scholar
• Cushman P, Forbes R, Lemer W, et al. Alcohol withdrawal syndromes: clinical management with lofexidine. Alcohol Clin Exp Res 1985; 9: 103–108
   PubMed Web of Science ®Google Scholar
• Adinoff B. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcohol Clin Exp Res 1994; 18: 874–878
   Google Scholar
• Blum K, Briggs A H, DeLallo L. Clonidine enhancement of ethanol withdrawal in mice. Subst Alcohol Actions Misuse 1983; 4: 59–63
   Google Scholar
• Robinson B J, Robinson G M, Maling T J, et al. Is clonidine useful in the treatment of alcohol withdrawal?. Alcohol Clin Exp Res 1989; 13: 95–98
   PubMed Web of Science ®Google Scholar
• Nutt D, Glue P, Molyneux S, et al. α2-Adrenoceptor function in alcohol withdrawal: a pilot study of the effects of IV clonidine in alcoholics and normals. Alcohol Clin Exp Res 1988; 12: 14–18
   PubMed Web of Science ®Google Scholar
• Grant S J, Huang Y H, Redmond DE. Benzodiazepines attenuate single-unit activity in the locus coeruleus. Life Sci 1980; 27: 2231–2236
   PubMed Web of Science ®Google Scholar
• Risby E D, Hsiao J K, Golden R N, et al. Intravenous alprazolam challenge in normal subjects: biochemical, cardiovascular, and behavioral effects. Psycho-pharmacology 1989; 99: 508–514
   Google Scholar
• Roy-Byrne P P, Lewis N, Villacres E, et al. Suppression of norepinephrine appearance rate in plasma by diazepam in humans. Life Sci 1988; 43: 1615–1623
   Google Scholar
• Fink K, Schultheiss R, Gothert M. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-o-aspartate (NMDA) and non-NMDA receptors. Br J Pharmacol 1992; 106: 67–72
   Google Scholar
• Engberg G, Hajos M. Alcohol withdrawal reactions as a result of adaptive changes of excitatory amino acid receptors. Naunyn Schmiedebergs Arch Pharmacol 1992; 346: 437–441
   PubMed Web of Science ®Google Scholar
• Goddard G V, McLntyre D C, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 1969; 25: 295–330
   PubMed Web of Science ®Google Scholar
• Ballenger J C, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 1978; 133: 1–14
   PubMed Web of Science ®Google Scholar
• Brown M E, Anton R F, Malcolm R, et al. Alcohol detoxification and withdrawal on kindling: clinical support for a kindling hypothesis. Biol Psychiatry 1988; 23: 507–514
   PubMed Web of Science ®Google Scholar
• Lechtenberg R, Worner TM. Relative kindling effect of detoxification and nondetoxification admissions in alcoholics. Alcohol Alcohol 1991; 26: 221–225
   PubMed Web of Science ®Google Scholar
• Poldrugo F, Snead OC. Electroencephalographic and behavioral correlates in rats during repeated ethanol withdrawal syndromes. Psychopharmacology 1984; 83: 140–146
   PubMed Web of Science ®Google Scholar
• Walker D W, Zornetzer SF. Alcohol withdrawal in mice: electroencephalographic and behavioral correlates. Electroencephalogr Clin Neurophysiol 1974; 36: 233–243
   Google Scholar
• McCown T J, Breese GR. Multiple withdrawals from chronic ethanol “kindles” inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcohol Clin Exp Res 1990; 14: 394–399
   Google Scholar
• Clemmesen L, Ingvar M, Hemmingsen R, et al. Local cerebral glucose consumption during ethanol withdrawal in the rat: effects of single and multiple episodes and previous convulsive seizures. Brain Res 1988; 453: 204–214
   PubMed Web of Science ®Google Scholar
• Becker H C, Hale RL. Positive relationship between the number of previous ethanol withdrawal episodes and the severity of subsequent withdrawal seizures in mice. Psychopharmacology, in press
   Google Scholar
• Hunt WA. Are binge drinkers more at risk of developing brain damage?. Alcohol 1993; 10: 559–561
   PubMed Web of Science ®Google Scholar
• Albright P S, Burnham WM. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical and amygdala seizures in the rat. Epilepsia 1980; 21: 681–689
   PubMed Web of Science ®Google Scholar
• Butler D, Messina RS. Alcohol withdrawal and carbamazepine. Alcohol 1986; 3: 113–129
   PubMed Web of Science ®Google Scholar
• Malcolm R, Ballenger J C, Sturgis E T, et al. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146: 617–621
   PubMed Web of Science ®Google Scholar
• Adamec RE. Does kindling model anything clinically relevant?. Biol Psychiatry 1990; 27: 249–279
   PubMed Web of Science ®Google Scholar
• Mendelson J H, Stein S. Serum Cortisol levels in alcoholic and nonalcoholic subjects during experimentally induced ethanol intoxication. Psychosom Med 1966; 28: 616–626
   Web of Science ®Google Scholar
• Pohorecky L A, Newman B, Sun J, et al. Acute and chronic ethanol ingestion and serotonin meta3bol-ism in rat brain. J Pharmacol Exp Ther 1978; 204: 424–432
   Google Scholar
• Tabakoff B, Hoffman PL. Neurochemical aspects of tolerance to and physical dependence on alcohol. Biology of Alcoholism, Vol. 7, B Kiss in, H. Begleiter. Plenum, New York 1983; 199–252
   Google Scholar
• Valimaki M, Pelkonen R, Harkonen M, et al. Hormonal changes in noncirrhotic male alcoholics during ethanol withdrawal. Alcohol Alcohol 1984; 19: 235–242
   PubMed Web of Science ®Google Scholar
• Adinoff B, Risher-Flowers D, De Jong J, et al. Disturbances of hypothalamic-pituitary-adrenal axis functioning during the ethanol withdrawal syndrome in six men. Am J Psychiatry 1991; 148: 1023–1025
   PubMed Web of Science ®Google Scholar
• Van Thiel D H, Gavaler J S, Cobb CF. Pseudo-Cush-ing syndrome and alcohol abuse. NIAAA Research Monograph 13: Ethanol Tolerance and Dependence: Endocrinological Aspects. U.S. Dept. of HHS, PHS, ADAMHA, Washington, DC 1983
   Google Scholar
• MacGregor RR. Alcohol and immune defense. JAMA 1986; 256: 1474–1471
   PubMed Web of Science ®Google Scholar
• Jerrells T R, Marietta C A, Gone G, et al. Effects of ethanol on immune function. Clinical Immunology Newsletter 1987; 8: 25–29
   Google Scholar
• Born J, De Kloet E R, Wenz H, et al. Gluco- and antimineralcorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991; 260: E183–E188
   Google Scholar
• Murphy B EP. Steroids and depression. J Steroid Biochem Molec Biol 1991; 38: 537–559
   PubMed Web of Science ®Google Scholar
• Wolkowitz O M, Reus V I, Weingartner H, et al. Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147: 1297–1303
   PubMed Web of Science ®Google Scholar
• Roberts A J, Chu H P, Crabbe J C, et al. Differential modulation by the stress axis of ethanol withdrawal seizure expression in WSP and WSR mice. Alcohol Clin Exp Res 1991; 15: 412–417
   PubMed Web of Science ®Google Scholar
• Sapolsky R M, Krey L C, McEwen BS. The neuroen-docrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986; 7: 284–301
   PubMed Web of Science ®Google Scholar
• Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623–634
   PubMed Web of Science ®Google Scholar
• Iorio K R, Tabakoff B, Hoffman PL. Glutamate-in-duced neurotoxicity is increased in cerebellar granule cells exposed chronically to ethanol. Eur J Pharmacol 1993; 248: 209–212
   PubMed Web of Science ®Google Scholar
• Lancaster RE. Alcohol, nitric oxide, and neurotoxicity: is there a connection?–a review. Alcohol Clin Exp Res 1992; 16: 539–541
   Google Scholar
• Steinberg G K, Kunis D, Saleh J, et al. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. J Cereb Blood Flow Metab 1991; 11: 1015–1024
   Google Scholar
• Jawad S, Richens A, Goodwin G, et al. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989; 30: 356–363
   PubMed Web of Science ®Google Scholar
• Olney JW, Labruyere J, Want G, et al. NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991; 254: 1515–1518
   PubMed Web of Science ®Google Scholar
• Sloviter RS. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 1987; 235: 73–76
   PubMed Web of Science ®Google Scholar
• Sapolsky R. Glucocorticoid toxicity in the hippocampus: temporal aspects of synergy with kainic acid. Neuroendocrinology 1986; 43: 440–444
   PubMed Web of Science ®Google Scholar
• Corda M G, Giorgi O, Mele S, et al. Enhanced sensitivity to fj-carboline inverse agonists in rats chronically treated with FG 7142. Brain Res Bull 1987; 19: 379–385
   Google Scholar
• Nutt D J, Glue P. Neurochemical insights into alcohol kindling. Human Psychopharmacology 1989; 4: 157–158
   Google Scholar
• Vezzani A, Wu H-Q, Montena E, et al. Role of the N-methyl-D-aspartate-type of hippocampal kindling in rats. Neurosci Lett 1988; 87: 63–68
   Google Scholar
• Weiss S RB, Post R M, Gold P W, et al. CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res 1986; 373: 345–351
   Google Scholar
• Adinoff B, Bone G HA, Linnoila M. Acute ethanol poisoning and the ethanol withdrawal syndrome. Medical Toxicology 1988; 3: 172–196
   Google Scholar
• Sellers E M, Naranjo C A, Harrison M, et al. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34: 822–926
   PubMed Web of Science ®Google Scholar
• Wartenberg A A, Nirenberg T D, Liepman M R, et al. Detoxification of alcoholics: improving care by symptom-triggered sedation. Alcohol Clin Exp Res 1990; 14: 71–75
   PubMed Web of Science ®Google Scholar
• Kalogeras K T, Calogero A E, Kuribayiashi T, et al. In vitro and in vivo effects of the triazolobenzodiazep-ine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J Clin Endocrinol Metab 1990; 70: 1462–1471
   PubMed Web of Science ®Google Scholar
• Pericic D, Lakic N, Manev H. Effect of diazepam on plasma corticosterone levels. Psychopharmacology 1984; 83: 79–81
   Google Scholar
• Deutsch J A, Walton NY. Diazepam maintenance of alcohol preference during alcohol withdrawal. Science 1977; 198: 197–199
   Google Scholar
• Olpe H-R, Baudry M, Jones R SG. Electrophysiological and neurochemical investigations on the action of carbamazepine on the rat hippocampus. Eur J Pharmacol 1985; 110: 71–80
   PubMed Web of Science ®Google Scholar
• Pisciotta AV. Carbamazepine: hematologic toxicity. Antiepileptic Drugs, DM Woodbury, JK Penry, CE. Pippenger. Raven Press, New York 1982; 533–541
   Google Scholar
• Post R M, Altshuler I X, Ketter R A, . Antiepileptic drugs in affective illness. Advances in Neurology, Vol. 55, D Smith, M. Trimble, et al. Raven, New York 1991; 239–277
   Google Scholar
• Keck P E, McElroy S L, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992; 12: 26S–41S
   Google Scholar